<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Med Genet</journal-id><journal-title>BMC Medical Genetics</journal-title><issn pub-type="epub">1471-2350</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-2350-4-5</article-id><article-id pub-id-type="pmid">12857359</article-id><article-id pub-id-type="doi">10.1186/1471-2350-4-5</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Mutation analysis of the cathepsin C gene in Indian families with Papillon-Lef&#x000e8;vre syndrome</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Selvaraju</surname><given-names>Veeriah</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>selvacell@rediffmail.com</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Markandaya</surname><given-names>Manjunath</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>mmanju@mrdg.iisc.ernet.in</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Prasad</surname><given-names>Pullabatla Venkata Siva</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>prasaderm@hotmail.com</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Sathyan</surname><given-names>Parthasarathy</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>sathyan.p@cbe.aravind.org</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Sethuraman</surname><given-names>Gomathy</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>kgsethu@yahoo.com</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Srivastava</surname><given-names>Satish Chandra</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>srivastavadr@yahoo.co.in</email></contrib><contrib id="A7" contrib-type="author"><name><surname>Thakker</surname><given-names>Nalin</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>nthakker@man.ac.uk</email></contrib><contrib id="A8" corresp="yes" contrib-type="author"><name><surname>Kumar</surname><given-names>Arun</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>karun@mrdg.iisc.ernet.in</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Molecular Reproduction Development and Genetics, Indian Institute of Science, Bangalore, India</aff><aff id="I2"><label>2</label>Department of Dermatology, Rajah Muthiah Medical College Hospital, Annamalai University, Chidambaram, India</aff><aff id="I3"><label>3</label>Aravind Eye Hospital, Coimbatore, India</aff><aff id="I4"><label>4</label>Department of Dermatology, All India Institute of Medical Sciences, New Delhi, India</aff><aff id="I5"><label>5</label>Department of Medical Genetics and Dentistry, University of Manchester, UK</aff><pub-date pub-type="collection"><year>2003</year></pub-date><pub-date pub-type="epub"><day>12</day><month>7</month><year>2003</year></pub-date><volume>4</volume><fpage>5</fpage><lpage>5</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2350/4/5"/><history><date date-type="received"><day>22</day><month>3</month><year>2003</year></date><date date-type="accepted"><day>12</day><month>7</month><year>2003</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2003 Selvaraju et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-statement><copyright-year>2003</copyright-year><copyright-holder>Selvaraju et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-holder></permissions><abstract><sec><title>Background</title><p>PLS is a rare autosomal recessive disorder characterized by early onset periodontopathia and palmar plantar keratosis. PLS is caused by mutations in the cathepsin C (<italic>CTSC</italic>) gene. Dipeptidyl-peptidase I encoded by the <italic>CTSC </italic>gene removes dipeptides from the amino-terminus of protein substrates and mainly plays an immune and inflammatory role. Several mutations have been reported in this gene in patients from several ethnic groups. We report here mutation analysis of the <italic>CTSC </italic>gene in three Indian families with PLS.</p></sec><sec sec-type="methods"><title>Methods</title><p>Peripheral blood samples were obtained from individuals belonging to three Indian families with PLS for genomic DNA isolation. Exon-specific intronic primers were used to amplify DNA samples from individuals. PCR products were subsequently sequenced to detect mutations. PCR-SCCP and ASOH analyses were used to determine if mutations were present in normal control individuals.</p></sec><sec><title>Results</title><p>All patients from three families had a classic PLS phenotype, which included palmoplantar keratosis and early-onset severe periodontitis. Sequence analysis of the <italic>CTSC </italic>gene showed three novel nonsense mutations (viz., p.Q49X, p.Q69X and p.Y304X) in homozygous state in affected individuals from these Indian families.</p></sec><sec><title>Conclusions</title><p>This study reported three novel nonsense mutations in three Indian families. These novel nonsense mutations are predicted to produce truncated dipeptidyl-peptidase I causing PLS phenotype in these families. A review of the literature along with three novel mutations reported here showed that the total number of mutations in the <italic>CTSC </italic>gene described to date is 41 with 17 mutations being located in exon 7.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>With an incidence of 1 to 4/million, Papillon-Lef&#x000e8;vre Syndrome (PLS, MIM 245000) is a rare autosomal recessive disorder with an onset usually by two to three years of age [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. The disease is mainly characterized by severe early onset periodontitis, leading to premature tooth shedding of both the deciduous and permanent teeth, alveolar bone destruction (such that by 15 years of age the patients are usually edentulous), and hyperkeratosis characteristically involving the palms and soles and sometimes the knees, elbows, knuckles, and back [<xref ref-type="bibr" rid="B1">1</xref>]. PLS can manifest itself as early as 2 months of age with the appearance of hyperkeratotic lesions of the hands and feet [<xref ref-type="bibr" rid="B3">3</xref>]. Other clinical features not often reported are an increased susceptibility to infections (especially furunculosis and pyoderma, pyogenic liver abscess etc.,) with recurrent fevers in childhood and calcification of the dura. Males and females are equally affected with no racial predominance [<xref ref-type="bibr" rid="B3">3</xref>]. Approximately one-third of the families show consanguinity [<xref ref-type="bibr" rid="B2">2</xref>].</p><p>PLS is a genetically homogeneous disorder with a locus mapped on chromosome 11q14-q21 [<xref ref-type="bibr" rid="B4">4</xref>-<xref ref-type="bibr" rid="B6">6</xref>]. Toomes et al. [<xref ref-type="bibr" rid="B7">7</xref>] have subsequently reported that loss-of-function mutations in the cathepsin C gene result in the PLS phenotype. The cathepsin C gene encodes a cysteine lysosomal protease also known as dipeptidyl-peptidase I which functions by removing dipeptides from the amino terminus of the protein substrate. It also has endopeptidase activity. It is highly expressed in various tissues such as the cells of the immune system (polymorphic nuclear leukocytes, alveolar macrophages and their precursors), and in the lungs, kidneys and other epithelial tissues [<xref ref-type="bibr" rid="B8">8</xref>]. Its main functions are thought to be protein degradation and pro-enzyme activation in addition to its immunological role [<xref ref-type="bibr" rid="B8">8</xref>]. The <italic>CTSC </italic>gene is over 46 kb long and consists of seven exons and six introns [<xref ref-type="bibr" rid="B7">7</xref>]. Several mutations have been reported in the <italic>CTSC </italic>gene in individuals from diverse ethnic groups. In addition, mutation in this gene was also detected in a Jewish-Hindu family with Haim-Munk syndrome [<xref ref-type="bibr" rid="B9">9</xref>] and prepubertal periodontitis [<xref ref-type="bibr" rid="B10">10</xref>]. We report here mutation analysis of the <italic>CTSC </italic>gene in three Indian families with members suffering from PLS. We also present a summary of cathepsin C mutations reported to date in PLS patients.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Patients</title><p>We have ascertained three families from the southern part of India, IISC-PLS1, IISC-PLS2 and IISC-PLS3 with PLS phenotype. Families IISC-PLS1 and IISC-PLS3 are non-consanguineous, whereas family IISC-PLS2 shows consanguinity. A total of 11 individuals including five patients were recruited for the study from these three families. All family members were examined in detail by clinicians and the patients with PLS were diagnosed according to previously established criteria [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B11">11</xref>]. This research followed the tenets of the Declaration of Helsinki. Informed consent was obtained from the individuals included in this study.</p></sec><sec><title>PCR amplification and mutation analysis</title><p>Genomic DNA samples were isolated from peripheral blood samples of all available members of three families using a Wizard<sup>&#x000ae; </sup>Genomic DNA Extraction kit (Promega Inc., USA). Genomic DNA from one affected member from each family was initially PCR amplified for all seven exons spanning the <italic>CTSC </italic>gene using pairs of exon-specific intronic primers. The primer sequences are described in Toomes et al. [<xref ref-type="bibr" rid="B7">7</xref>]. PCR amplification was carried out in a 25 &#x003bc;l reaction volume containing ~100 ng genomic DNA, 60 ng of each primer, 200 &#x003bc;mol of each dNTP, 1 unit Taq DNA polymerase (Bangalore Genei<sup>&#x000ae;</sup>, India) in a standard PCR buffer supplied by the manufacturer. Amplification was performed in a Minicycler&#x02122; (MJ Research<sup>&#x000ae; </sup>Inc., USA) under the following conditions: an initial denaturation at 95&#x000b0;C for 2 min was followed by 35 cycles at 94&#x000b0;C for 30 s, 62&#x000b0;C for 30 s, 72&#x000b0;C for 1 min and a final extension of 5 min at 72&#x000b0;C. PCR amplified products were purified using a Wizard<sup>&#x000ae; </sup>PCR Preps DNA Purification System (Promega Inc., USA) and subjected to direct sequencing using an <italic>fmo</italic>l<sup>&#x000ae; </sup>DNA Cycle Sequencing System kit (Promega Inc., USA) according to the manufacturer's instruction. Once a nucleotide change was detected in a patient, other available members from the family were also sequenced to determine if the change was also present in them. PCR-SSCP and allele-specific oligonucleotide hybridization (ASOH) analyses were used to determine if a nucleotide change was present in ethnically matched normal controls as described in Kumar et al. [<xref ref-type="bibr" rid="B12">12</xref>] and Cormand et al. [<xref ref-type="bibr" rid="B13">13</xref>] respectively.</p></sec></sec><sec><title>Results</title><p>All patients had a history of the onset of the disorder by the age of 2 to 3 years. Examination of these patients revealed that they all had severe palmar plantar keratoderma, and severe periodontitis (except individual II-2 from family IISC-PLS3) leading to shedding of most of their teeth. Patient II-2 from family IISC-PLS3 had a subsidence of periodontitis, as he was edentulous, having lost all his teeth by the age of 12 years. Patients IV-3 and IV-4 from family IISC-PLS2 also had hyperkeratosis of the knuckles, knees and elbows in addition to palmar plantar keratoderma and severe periodontitis. Fig. <xref ref-type="fig" rid="F1">1</xref> illustrates clinical manifestations of PLS. Individual II-2 from family IISC-PLS3 was known to have frequent episodes of infections especially of the skin and recurrent fevers in childhood, suggesting an increased susceptibility to microbial infections. Heterozygous parents from families IISC-PLS1 and IISC-PLS2 and heterozygous siblings (IV-1 and IV-5) from family IISC-PLS2 were unaffected.</p><fig position="float" id="F1"><label>Figure 1</label><caption><p>Clinical features of PLS. (A) Periodontitis affecting secondary dentition in the patient IV-3 at 16 yrs of age from the family IISC-PLS2. (B) Orthopantomogram of oral cavity of patient IV-3 at 11 years of age from the family IISC-PLS2 with severe periodontitis. All teeth in this patient are permanent and there is an extensive loss of alveolar bone both in maxillary and mandibular arches. (C) Periodontitis in the patient IV-4 at 12 years of age from the family IISC-PLS2. (D) Orthopantomogram of oral cavity of patient IV-4 at 12 years of age from the family IISC-PLS2 with severe periodontitis. All teeth in this patient are permanent and there is an extensive loss of alveolar bone both in maxillary and mandibular arch. (E) Knuckle hyperkeratosis in the patient IV-4 of the family IISC-PLS2. (F) Plantar hyperkeratosis in the patient IV-3 of the family IISC-PLS2. (G) Palmar hyperkeratosis (punctate type) in the patient II-2 of the family IISC-PLS3.</p></caption><graphic xlink:href="1471-2350-4-5-1"/></fig><p>We initially screened PCR products of all seven exons of the <italic>CTSC </italic>gene for mutation(s) in one patient from each family using DNA sequencing technique (Fig. <xref ref-type="fig" rid="F2">2</xref>). Once the mutation was detected, it was confirmed in other members of the family. Sequence analysis of the exon 1 PCR product from the patient III-1 of the family IISC-PLS1 showed a nucleotide change in a homozygous state at position 145 from C&#x0003e;T (c.145C&#x0003e;T) which introduced a premature stop codon in the exon 1 (p.Q49X) (Fig. <xref ref-type="fig" rid="F2">2A</xref>). This change was also present in affected sibling III-2 in a homozygous state, whereas both parents were heterozygous for this change (Fig. <xref ref-type="fig" rid="F2">2A</xref>). PCR-SSCP analysis showed that this change was not present in 60 normal chromosomes (data not shown).</p><fig position="float" id="F2"><label>Figure 2</label><caption><p>Three novel nonsense mutations in the <italic>CTSC </italic>gene. The numbering of the wild type sequence is based upon the cDNA sequence of the <italic>CTSC </italic>gene (GenBank accession # NM-001814). (A) Pedigree diagram of the family IISC-PLS1. DNA samples from individuals II-4, II-5, III-1 and III-2 were analysed from this family. Direct sequencing of the PCR products from both heterozygous parents II-4 and II-5 and homozygous patients III-1 and III-2 are shown on the right. Arrows indicate the145C&#x0003e;T nucleotide change. (B) Pedigree diagram of the family IISC-PLS2. DNA samples from individuals III-3, III-4, IV-1, IV-3, IV-4 and IV-5 were analysed from this family. Direct sequencing of the PCR products from both heterozygous parents III-3 and III-4, and homozygous patients IV-3 and IV-4 are shown on the right. Arrows indicate the 205C&#x0003e;T nucleotide change. (C) Pedigree diagram of the family IISC-PLS3. DNA sample from only individual II-2 was analysed from this family. Direct sequencing of the PCR product from the patient II-2 is shown on the right. Arrow indicates the 912 C&#x0003e;A change.</p></caption><graphic xlink:href="1471-2350-4-5-2"/></fig><p>Sequence analysis of the exon 2 PCR-product from the patient IV-3 of the family IISC-PLS2 showed a nucleotide change in a homozygous state at position 205 from C&#x0003e;T (c.205C&#x0003e;T) which introduced a premature stop codon in the exon 2 (p.Q69X) (Fig. <xref ref-type="fig" rid="F2">2B</xref>). As expected, affected sibling IV-4 from this family was also homozygous for this change, whereas both parents (Fig. <xref ref-type="fig" rid="F2">2B</xref>) and both unaffected siblings (IV-1 and IV-5) were heterozygous for this change (data not shown). Since PCR-SSCP analysis failed to demonstrate this change, we used ASOH analysis to determine if this change was present in normal controls. ASOH analysis showed that this change was not present in 60 normal chromosomes (data not shown).</p><p>Sequence analysis of the exon 7 PCR product from the patient II-2 of the family IISC-PLS3 (Fig. <xref ref-type="fig" rid="F2">2C</xref>) showed a nucleotide change in a homozygous state at position 912 from C&#x0003e;A (c.912C&#x0003e;A) which introduced a premature stop codon in the exon 7 (p.Y304X). PCR-SSCP analysis showed that this change was not present in 60 normal chromosomes (data not shown).</p></sec><sec><title>Discussion</title><p>All three nucleotide changes reported here fulfilled the criteria of a mutation [<xref ref-type="bibr" rid="B12">12</xref>] as these changes were not present in the controls and result in the truncation of the <italic>CTSC </italic>encoded enzyme dipeptidyl-peptidase I with the introduction of premature stop codons. The c.145C&#x0003e;T mutation in the family IISC-PLS1 would be expected to produce an abnormally short enzyme dipeptidyl-peptidase I of 49 amino acid length in contrast to a normal enzyme of 463 amino acids [<xref ref-type="bibr" rid="B8">8</xref>]. Similarly, the c.205C&#x0003e;T change in the family IISC-PLS2 would be expected to produce a truncated enzyme with 69 amino acids and the c.912C&#x0003e;A mutation in the family IISC-PLS3 would be expected to produce a truncated enzyme with 304 amino acids [<xref ref-type="bibr" rid="B8">8</xref>]. These nonsense mutations would reduce any residual dipeptidyl peptidase I activity through nonsense mutation-mediated decay of the transcript, which might result in very low steady-state levels of <italic>CTSC </italic>messages leading to the disease phenotype in patients reported in the present study. In addition, this protein is lysosomal and may not be transported to the organelle if truncated, leading to the disease phenotype. It has been suggested that dipeptidyl peptidase I is involved in a wide variety of immune and inflammatory responses that include the activation of phagocytic cells and T-lymphocytes, leading to the final elimination of pathogens [<xref ref-type="bibr" rid="B7">7</xref>]. Therefore, inactivation of the dipeptidyl-peptidase I due to mutations would result in the blocking of these responses leading to infection of the gums and surrounding tissues by pathogens, ultimately leading to tooth loss. Alternatively, dipeptidyl-peptidase I might influence periodontal disease progression through its role in epithelial differentiation or desquamation. Since the sulcular and junctional epithelium represent the first line of defense against pathogens, their aberrant differentiation due to mutant <italic>CTSC </italic>gene may alter the mechanical barrier to periodontal pathogens [<xref ref-type="bibr" rid="B7">7</xref>].</p><p>A review of the literature on the number of total mutations reported in the <italic>CTSC </italic>gene shows a total of 38 mutations [[<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B14">14</xref>-<xref ref-type="bibr" rid="B22">22</xref>], <ext-link ext-link-type="uri" xlink:href="http://www.genetics.pitt.edu/CTSC/"/>] with 27 being novel and 11 recurrent (Table <xref ref-type="table" rid="T1">1</xref>). The total number of known mutations in the <italic>CTSC </italic>gene is now 41. Of these, 11 mutations are recurrent (Table <xref ref-type="table" rid="T1">1</xref>). A majority of mutations (a total of 17 mutations) are located in exon 7 (Table <xref ref-type="table" rid="T1">1</xref>). Of the known mutations, 11 are nonsense, 20 are missense, 2 are insertions, 7 are deletions and 1 is a splice site mutation (Table <xref ref-type="table" rid="T1">1</xref>). This suggests that although most of the mutations (a total of 17) are located in exon 7, mutations are scattered across the coding region of the <italic>CTSC </italic>gene, suggesting that mutation analysis of the cathepsin C gene will require evaluation of the complete gene. Missense mutation c.815G&#x0003e;C (p.R272P) has been found in nine families including four families from Saudi Arabia. The haplotype analysis has shown that these four Saudi Arabian families have inherited this mutation from a common ancestor [<xref ref-type="bibr" rid="B17">17</xref>]. Similarly, Zhang et al. [<xref ref-type="bibr" rid="B17">17</xref>] have demonstrated that a recurrent nonsense mutation c.856C&#x0003e;T (p.Q286X) found in three families from Turkey has a common ancestral origin. A nonsense mutation c.1286G&#x0003e;A (p.W429X) found in four families from Turkey has also been found to have a common ancestral origin by haplotype analysis [<xref ref-type="bibr" rid="B17">17</xref>]. On the other hand, it is not clear if five recurrent mutations- c.96T&#x0003e;G (p.Y32X) found in three families, splice site mutation IVS3_1G&#x0003e;A found in two families, c.901G&#x0003e;A (p.G301S) found in three families, c.1015C&#x0003e;T (p.R339C) found in four families and c.1040A&#x0003e;G (p.Y347C) found in two families- have originated from common ancestors or these mutation sites represent mutation hotspots.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Disease-causing mutations in the cathepsin C gene detected so far.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Sl#</td><td align="left">Exon</td><td align="left">Type</td><td align="left">Mutation</td><td align="left">Effect</td><td align="left">Origin / Disease</td><td align="left">No. of families</td></tr></thead><tbody><tr><td align="left">1</td><td align="left">1</td><td align="left">Nonsense</td><td align="left">c.72C&#x0003e;A (p.C24X)</td><td align="left">Premature stop</td><td align="left">Moroccan <sup>19 </sup>/ PLS</td><td align="left">1</td></tr><tr><td align="left">2</td><td align="left">1</td><td align="left">Nonsense</td><td align="left">c.96T&#x0003e;G (p.Y32X)</td><td align="left">Premature stop</td><td align="left">Mexican <sup>20</sup>, &#x000a7;Caucasian <sup>20</sup>, French <sup>19 </sup>/ PLS</td><td align="left">3</td></tr><tr><td align="left">3</td><td align="left">1</td><td align="left">Nonsense</td><td align="left">c.145C&#x0003e;T (p.Q49X)</td><td align="left">Premature stop</td><td align="left">Indian <sup>A </sup>/ PLS</td><td align="left">1</td></tr><tr><td align="left">4</td><td align="left">1</td><td align="left">Missense</td><td align="left">c.116G&#x0003e;C (p.W39S)</td><td align="left">AHCR**</td><td align="left">Puerto Rican <sup>16 </sup>/ PLS</td><td align="left">1</td></tr><tr><td align="left">5</td><td align="left">2</td><td align="left">Nonsense</td><td align="left">c.205C&#x0003e;T (p.Q69X)</td><td align="left">Premature stop</td><td align="left">Indian <sup>A </sup>/ PLS</td><td align="left">1</td></tr><tr><td align="left">6</td><td align="left">2</td><td align="left">Deletion</td><td align="left">c.199_222del (p. 67_74)</td><td align="left">Frameshift</td><td align="left">* Chinese <sup>15 </sup>/ PLS</td><td align="left">1</td></tr><tr><td align="left">7</td><td align="left">3</td><td align="left">Missense</td><td align="left">c.380A&#x0003e;C (p. H127P)</td><td align="left">AHCR**</td><td align="left">French <sup>19 </sup>/ PLS</td><td align="left">1</td></tr><tr><td align="left">8</td><td align="left">3</td><td align="left">Missense</td><td align="left">c.415G&#x0003e;A (p.G139R)</td><td align="left">AHCR**</td><td align="left">&#x000a7;S Caucasian <sup>20 </sup>/ PLS</td><td align="left">1</td></tr><tr><td align="left">9</td><td align="left">3</td><td align="left">Insertion</td><td align="left">c.445_446insATGT (p.V149fsX157)</td><td align="left">Frameshift &#x00026; premature stop</td><td align="left">Indian <sup>15 </sup>/ PLS</td><td align="left">1</td></tr><tr><td align="left">10</td><td></td><td align="left">Splice site (Intron 3)</td><td align="left">IVS3_1G&#x0003e;A</td><td align="left">Altered splicing</td><td align="left">Egyptian <sup>7</sup>, Jordanian <sup>22 </sup>/ PLS</td><td align="left">2</td></tr><tr><td align="left">11</td><td align="left">4</td><td align="left">Nonsense</td><td align="left">c.545G&#x0003e;A (p.W185X)</td><td align="left">Premature stop</td><td align="left">Brazilian <sup>21 </sup>/ PLS</td><td align="left">1</td></tr><tr><td align="left">12</td><td align="left">4</td><td align="left">Missense</td><td align="left">c.587T&#x0003e;C (p.L196P)</td><td align="left">AHCR**</td><td align="left">Brazilian <sup>3 </sup>/ PLS</td><td align="left">1</td></tr><tr><td align="left">13</td><td align="left">4</td><td align="left">Insertion</td><td align="left">622_623insC (p.H208fsX223)</td><td align="left">Frameshift &#x00026; Premature stop</td><td align="left">Turkish <sup>15 </sup>/ PLS</td><td align="left">1</td></tr><tr><td align="left">14</td><td align="left">4</td><td align="left">Nonsense</td><td align="left">c.628C&#x0003e;T (p.R210X)</td><td align="left">Premature stop</td><td align="left">Lebanese<sup>7</sup>, Algerian <sup>19 </sup>/ PLS</td><td align="left">2</td></tr><tr><td align="left">15</td><td align="left">5</td><td align="left">Nonsense</td><td align="left">c.704G&#x0003e;A (p.W235X)</td><td align="left">Premature stop</td><td align="left">Iranian <sup>15 </sup>/ PLS</td><td align="left">1</td></tr><tr><td align="left">16</td><td align="left">5</td><td align="left">Missense</td><td align="left">c.706G&#x0003e;T (p.D236Y)</td><td align="left">AHCR**</td><td align="left">&#x003c6; Spanish <sup>18 </sup>/ PLS</td><td align="left">1</td></tr><tr><td align="left">17</td><td align="left">5</td><td align="left">Deletion</td><td align="left">c.711del14</td><td align="left">Frameshift &#x00026; Premature stop</td><td align="left">Algerian <sup>19 </sup>/ PLS</td><td align="left">1</td></tr><tr><td align="left">18</td><td align="left">5</td><td align="left">Missense</td><td align="left">c.745G&#x0003e;T (p.V249F)</td><td align="left">AHCR**</td><td align="left">Indian-Pakistani <sup>7 </sup>/ PLS</td><td align="left">1</td></tr><tr><td align="left">19</td><td align="left">5</td><td align="left">Nonsense</td><td align="left">c.748C&#x0003e;T (p.R250X)</td><td align="left">Premature stop</td><td align="left">Turkish <sup>15 </sup>/ PLS</td><td align="left">1</td></tr><tr><td align="left">20</td><td align="left">5</td><td align="left">Missense</td><td align="left">c.755A&#x0003e;T (p.Q252L)</td><td align="left">AHCR**</td><td align="left">Egyptian <sup>7 </sup>/ PLS</td><td align="left">1</td></tr><tr><td align="left">21</td><td align="left">6</td><td align="left">Missense</td><td align="left">c.815G&#x0003e;C (p.R272P)</td><td align="left">AHCR**</td><td align="left">Lebanese<sup>7</sup>, Turkish <sup>15</sup>, &#x000a7;Caucasian<sup>20</sup>, (4) Saudi <sup>17</sup>, Holland<sup>19</sup>, French <sup>19 </sup>/ PLS</td><td align="left">9</td></tr><tr><td align="left">22</td><td align="left">6</td><td align="left">Nonsense</td><td align="left">c.856C&#x0003e;T (p.Q286X)</td><td align="left">Premature stop</td><td align="left">Turkish <sup>9,14,17 </sup>/ PLS</td><td align="left">3</td></tr><tr><td align="left">23</td><td align="left">6</td><td align="left">Missense</td><td align="left">c.857A&#x0003e;G (p.Q286R)</td><td align="left">AHCR**</td><td align="left">Indian <sup>9</sup>, Spanish<sup>18 </sup>/ HMS, PLS</td><td align="left">2</td></tr><tr><td align="left">24</td><td align="left">6</td><td align="left">Missense</td><td align="left">c.872G&#x0003e;A (p.C291Y)</td><td align="left">AHCR**</td><td align="left">&#x003c6; Spanish <sup>18 </sup>/PLS</td><td align="left">1</td></tr><tr><td align="left">25</td><td align="left">7</td><td align="left">Missense</td><td align="left">c.898G&#x0003e;A (p.G300S)</td><td align="left">AHCR**</td><td align="left">&#x003a6; Vietnamese <sup>15 </sup>/ PLS</td><td align="left">1</td></tr><tr><td align="left">26</td><td align="left">7</td><td align="left">Missense</td><td align="left">c.899G&#x0003e;A (p.G300D)</td><td align="left">AHCR**</td><td align="left">Saudi <sup>17 </sup>/ PLS</td><td align="left">1</td></tr><tr><td align="left">27</td><td align="left">7</td><td align="left">Missense</td><td align="left">c.901G&#x0003e;A (p.G301S)</td><td align="left">AHCR**</td><td align="left">Indian-Pakistani <sup>7</sup>, Iranian <sup>15</sup>, Japanese <sup>16 </sup>/ PLS</td><td align="left">3</td></tr><tr><td align="left">28</td><td align="left">7</td><td align="left">Missense</td><td align="left">c.902G&#x0003e;T (p.G301V)</td><td align="left">AHCR**</td><td align="left">Iranian <sup>15 </sup>/ PLS</td><td align="left">1</td></tr><tr><td align="left">29</td><td align="left">7</td><td align="left">Missense</td><td align="left">c.910T&#x0003e;A (p.Y304N)</td><td align="left">AHCR**</td><td align="left">Panamanian <sup>15 </sup>/ PLS</td><td align="left">1</td></tr><tr><td align="left">30</td><td align="left">7</td><td align="left">Nonsense</td><td align="left">c.912C&#x0003e;A (p.Y304X)</td><td align="left">Premature stop</td><td align="left">Indian <sup>A </sup>/ PLS</td><td align="left">1</td></tr><tr><td align="left">31</td><td align="left">7</td><td align="left">Missense</td><td align="left">c.956A&#x0003e;G (p.E319G)</td><td align="left">AHCR**</td><td align="left">Iranian <sup>15 </sup>/ PLS</td><td align="left">1</td></tr><tr><td align="left">32</td><td align="left">7</td><td align="left">Deletion</td><td align="left">c.984del7</td><td align="left">Frameshift &#x00026; Premature stop</td><td align="left">French <sup>19 </sup>/ PLS</td><td align="left">1</td></tr><tr><td align="left">33</td><td align="left">7</td><td align="left">Missense</td><td align="left">c.1015C&#x0003e;T (p.R339C)</td><td align="left">AHCR**</td><td align="left">Egyptian <sup>7,15</sup>, Turkish<sup>10</sup>, Martinique <sup>19 </sup>/ PLS</td><td align="left">4</td></tr><tr><td align="left">34</td><td align="left">7</td><td align="left">Deletion</td><td align="left">c.1028_1029delCT (p.S343X)</td><td align="left">Frameshift &#x00026; Premature stop</td><td align="left">Turkish <sup>14 </sup>/ PLS</td><td align="left">1</td></tr><tr><td align="left">35</td><td align="left">7</td><td align="left">Missense</td><td align="left">c.1040A&#x0003e;G (p.Y347C)</td><td align="left">AHCR**</td><td align="left">Indian-Pakistani<sup>7</sup>, Jordanian <sup>10 </sup>/ PLS, PPP</td><td align="left">2</td></tr><tr><td align="left">36</td><td align="left">7</td><td align="left">Deletion</td><td align="left">c.1047delA (p.G349fsX359)</td><td align="left">Frameshift &#x00026; Premature stop</td><td align="left">Turkish <sup>14 </sup>/ PLS</td><td align="left">1</td></tr><tr><td align="left">37</td><td align="left">7</td><td align="left">Deletion</td><td align="left">c.1056delT</td><td align="left">Frameshift &#x00026; Premature stop</td><td align="left">French <sup>19 </sup>/ PLS</td><td align="left"><sup>1</sup></td></tr><tr><td align="left">38</td><td align="left">7</td><td align="left">Deletion</td><td align="left">c.1141delC (p.L381fsX393)</td><td align="left">Frameshift &#x00026; Premature stop</td><td align="left">&#x000a7;S Caucasian<sup>20</sup>, French <sup>19 </sup>/ PLS</td><td align="left">2</td></tr><tr><td align="left">39</td><td align="left">7</td><td align="left">Nonsense</td><td align="left">c.1286G&#x0003e;A (p.W429X)</td><td align="left">Premature stop</td><td align="left">Turkish <sup>14,15 </sup>/ PLS</td><td align="left">4</td></tr><tr><td align="left">40</td><td align="left">7</td><td align="left">Missense</td><td align="left">c.1287G&#x0003e;C (p. W429C)</td><td align="left">AHCR**</td><td align="left">French<sup>19 </sup>/ PLS</td><td align="left">1</td></tr><tr><td align="left">41</td><td align="left">7</td><td align="left">Missense</td><td align="left">c.1360A&#x0003e;G (p.E447G)</td><td align="left">AHCR**</td><td align="left">&#x003a6; Vietnamese <sup>15 </sup>/ PLS</td><td align="left">1</td></tr></tbody></table><table-wrap-foot><p>[A] Novel mutations identified in this study; [<xref ref-type="bibr" rid="B20">20</xref>] Zhang <italic>et al</italic>. 2002; [<xref ref-type="bibr" rid="B16">16</xref>] Nakano <italic>et al. </italic>2001; [<xref ref-type="bibr" rid="B15">15</xref>] Hart <italic>et al. </italic>2000c; [<xref ref-type="bibr" rid="B17">17</xref>] Zhang <italic>et al. </italic>2001; [<xref ref-type="bibr" rid="B18">18</xref>] Allende <italic>et al. </italic>2001; [<xref ref-type="bibr" rid="B19">19</xref>] Lefevre <italic>et al. </italic>2001; [<xref ref-type="bibr" rid="B7">7</xref>]Toomes <italic>et al. </italic>1999; [<xref ref-type="bibr" rid="B3">3</xref>] Cury <italic>et al. </italic>2002; [<xref ref-type="bibr" rid="B21">21</xref>] Hart <italic>et al. </italic>2002; [<xref ref-type="bibr" rid="B10">10</xref>] Hart <italic>et al. </italic>2000b; [<xref ref-type="bibr" rid="B14">14</xref>] Hart <italic>et al. </italic>1999; [<xref ref-type="bibr" rid="B22">22</xref>] Nusier <italic>et al. </italic>2002; [<xref ref-type="bibr" rid="B9">9</xref>] Hart <italic>et al. </italic>2000a. * Proband was a compound heterozygote for the 199&#x02013;222 del and 458C&#x0003e;T mutations ** Alteration of highly conserved residue. &#x000a7;Probands were compound heterozygote for the 96T&#x0003e;G and 815G&#x0003e;C mutations. &#x000a7;S Proband was a compound heterozygote for the 415G&#x0003e;A and 1141delC mutations. &#x003c6; Proband was a compound heterozygote for the 706G&#x0003e;T and 872G&#x0003e;A mutations. &#x003a6; Proband was a compound heterozygote for the 898G&#x0003e;A and 1360A&#x0003e;G mutations.</p></table-wrap-foot></table-wrap><p>An interesting feature of the cathepsin C gene is that mutations in this gene also result in two other closely related conditions: the Haim-Munk Syndrome [<xref ref-type="bibr" rid="B9">9</xref>], and prepubertal periodontitis [<xref ref-type="bibr" rid="B10">10</xref>]. A common clinical manifestation in all three syndromes is severe early-onset periodontitis. Haim-Munk syndrome (HMS) is an ethnically specific disorder described only in Jews of South Indian origin (the so called "Cochin Jews"). The clinical phenotypes of HMS overlap with PLS and prepubertal periodontitis (PPP) and include congenital keratosis palmoplantaris, onychogryposis, periodontitis, pes planus, arachnodactyly, and acroosteolysis. Thus HMS, PPP and PLS seem to be allelic variants. A common mutation c.1040A&#x0003e;G has been shown to cause two distinct phenotypes, PLS and PPP, suggesting that other factors such as genetic or environmental, play a role in the ultimate phenotype [<xref ref-type="bibr" rid="B15">15</xref>]. A missense mutation c.857A&#x0003e;G (p.Q286R) in the <italic>CTSC </italic>gene has been found to cause HMS [<xref ref-type="bibr" rid="B9">9</xref>]. This mutation has also been detected in a homozygous state in a Spanish PLS patient, suggesting that the HMS and PLS are clinical variants of the same homozygous cathepsin C gene mutation [<xref ref-type="bibr" rid="B18">18</xref>]. It is possible that a part of the clinical manifestations in HMS patients (viz., hyperkeratosis and periodontitis) is caused by a mutation in the <italic>CTSC </italic>gene where as other features of HMS (viz., onychogryposis, pes planus, arachnodactyly, and acroosteolysis) are caused by mutations in another hitherto undescribed gene. However, this possibility remains to be proven.</p><p>Hart et al. al. [<xref ref-type="bibr" rid="B15">15</xref>] have carried out genotype-phenotype correlation using 22 probands on whom genotype and phenotype data were available. The categories for genotype were mutations in the pro-region and mutations in the mature enzyme [<xref ref-type="bibr" rid="B15">15</xref>]. The categories for phenotypes were the presence or absence of transgressions of the hyperkeratosis lesions on the knees and elbows [<xref ref-type="bibr" rid="B15">15</xref>]. No correlation was found as affected subjects with transgressions of dermal lesions onto knees or elbows or both had mutations in both the pro- and mature regions of the enzyme [<xref ref-type="bibr" rid="B15">15</xref>]. Our analysis on 41 probands suggested a similar finding. Our analysis also did not find any correlation between the types of mutations (missense, nonsense, insertion, deletion and splice site) and the presence or absence of the lesions on the knees or elbows or both as observed previously by Hart et al. [<xref ref-type="bibr" rid="B15">15</xref>].</p></sec><sec><title>Conclusions</title><p>In this study, we have reported three novel nonsense mutations responsible for PLS phenotype in three Indian families. In addition, our review of the literature showed that the total number of mutations described to date in the cathepsin C gene, along with the ones reported during the present study, reaches to 41 including a common mutation reported in HMS patients.</p></sec><sec><title>Competing interests</title><p>None declared</p></sec><sec><title>Authors' contributions</title><p>VS carried out the molecular genetic studies. MM coordinated specimen collection and wrote the first draft of the manuscript. PVSP, PS, GS and SCS ascertained the families. NT provided primers and their PCR conditions. AK conceived the study, carried out the molecular genetic studies along with VS and drafted the final version of the manuscript</p></sec><sec><title>Pre-publication history</title><p>The pre-publication history for this paper can be accessed here:</p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2350/4/5/prepub"/></p></sec></body><back><ack><sec><title>Acknowledgements</title><p>We thank the reviewers, Drs. Douglas Peter C. Dickinson and Jouni Uitto, for their valuable suggestions to improve the manuscript.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Papillon</surname><given-names>MN</given-names></name><name><surname>Lefevre</surname><given-names>B</given-names></name></person-group><article-title>Two cases of familial symmetric palmoplanter keratosis (Maleda's disease) in a brother and his sister. Alterations in both cases (in French)</article-title><source>Bull Soc Francaise Dermatologie Syphiligraphie</source><year>1924</year><volume>31</volume><fpage>81</fpage><lpage>84</lpage></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gorlin</surname><given-names>RJ</given-names></name><name><surname>Sedano</surname><given-names>H</given-names></name><name><surname>Anderson</surname><given-names>VF</given-names></name></person-group><article-title>The syndrome of palmo-plantar hyperkeratosis and premature periodontal destruction of the teeth. A clinical and genetic analysis of the Papillon-Lefevre syndrome</article-title><source>J Pediatr</source><year>1964</year><volume>65</volume><fpage>895</fpage><lpage>908</lpage><pub-id pub-id-type="pmid">14244097</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cury</surname><given-names>VF</given-names></name><name><surname>Costa</surname><given-names>JE</given-names></name><name><surname>Gomez</surname><given-names>RS</given-names></name><name><surname>Boson</surname><given-names>WL</given-names></name><name><surname>Loures</surname><given-names>CG</given-names></name><name><surname>Marco</surname><given-names>LD</given-names></name></person-group><article-title>A novel mutation of the cathepsin C gene in Papillon-Lefevre syndrome</article-title><source>J Periodontol</source><year>2002</year><volume>73</volume><fpage>307</fpage><lpage>312</lpage><pub-id pub-id-type="pmid">11922261</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>J</given-names></name><name><surname>Blanchet-Bardon</surname><given-names>C</given-names></name><name><surname>Prud'homme</surname><given-names>J-F</given-names></name><name><surname>Pavek</surname><given-names>S</given-names></name><name><surname>Steijlen</surname><given-names>PM</given-names></name><name><surname>Dubertret</surname><given-names>L</given-names></name><name><surname>Weissenbach</surname><given-names>J</given-names></name></person-group><article-title>Mapping of Papillon-Lefevre syndrome to the chromosome 11q14 region</article-title><source>Eur J Hum Genet</source><year>1997</year><volume>51</volume><fpage>156</fpage><lpage>160</lpage><pub-id pub-id-type="pmid">9272739</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laass</surname><given-names>MW</given-names></name><name><surname>Hennies</surname><given-names>HC</given-names></name><name><surname>Preis</surname><given-names>S</given-names></name><name><surname>Stevens</surname><given-names>HP</given-names></name><name><surname>Jung</surname><given-names>M</given-names></name><name><surname>Leigh</surname><given-names>IM</given-names></name><name><surname>Wienker</surname><given-names>TF</given-names></name><name><surname>Reis</surname><given-names>A</given-names></name></person-group><article-title>Localization of a gene for Papillon-Lefevre syndrome to chromosome 11q14-q21 by homozygosity mapping</article-title><source>Hum Genet</source><year>1997</year><volume>101</volume><fpage>376</fpage><lpage>382</lpage><pub-id pub-id-type="pmid">9439671</pub-id><pub-id pub-id-type="doi">10.1007/s004390050645</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hart</surname><given-names>TC</given-names></name><name><surname>Bowden</surname><given-names>DW</given-names></name><name><surname>Ghaffar</surname><given-names>KA</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Cutler</surname><given-names>CW</given-names></name><name><surname>Cebeci</surname><given-names>I</given-names></name><name><surname>Efeoglu</surname><given-names>A</given-names></name><name><surname>Firatli</surname><given-names>E</given-names></name></person-group><article-title>Sublocalization of the Papillon-Lefevre syndrome on chromosome 11q14-q21</article-title><source>Am J Med Genet</source><year>1998</year><volume>79</volume><fpage>134</fpage><lpage>139</lpage><pub-id pub-id-type="pmid">9741471</pub-id><pub-id pub-id-type="doi">10.1002/(SICI)1096-8628(19980901)79:2&#x0003c;134::AID-AJMG9&#x0003e;3.0.CO;2-Q</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Toomes</surname><given-names>C</given-names></name><name><surname>James</surname><given-names>J</given-names></name><name><surname>Wood</surname><given-names>AJ</given-names></name><name><surname>CL</surname><given-names>Wu</given-names></name><name><surname>McCormick</surname><given-names>D</given-names></name><name><surname>Lench</surname><given-names>N</given-names></name><name><surname>Hewitt</surname><given-names>C</given-names></name><name><surname>Moynihan</surname><given-names>L</given-names></name><name><surname>Roberts</surname><given-names>E</given-names></name><name><surname>Woods</surname><given-names>CG</given-names></name><name><surname>Markham</surname><given-names>A</given-names></name><name><surname>Wong</surname><given-names>M</given-names></name><name><surname>Widmer</surname><given-names>R</given-names></name><name><surname>Ghaffar</surname><given-names>KA</given-names></name><name><surname>Pemberton</surname><given-names>M</given-names></name><name><surname>Hussein</surname><given-names>IR</given-names></name><name><surname>Temtamy</surname><given-names>SA</given-names></name><name><surname>Davies</surname><given-names>R</given-names></name><name><surname>Read</surname><given-names>AP</given-names></name><name><surname>Sloan</surname><given-names>P</given-names></name><name><surname>Dixon</surname><given-names>MJ</given-names></name><name><surname>Thakker</surname><given-names>NS</given-names></name></person-group><article-title>Loss-of function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis</article-title><source>Nat Genet</source><year>1999</year><volume>23</volume><fpage>421</fpage><lpage>424</lpage><pub-id pub-id-type="pmid">10581027</pub-id><pub-id pub-id-type="doi">10.1038/70525</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>NV</given-names></name><name><surname>Rao</surname><given-names>GV</given-names></name><name><surname>Hoidal</surname><given-names>JR</given-names></name></person-group><article-title>Human dipeptidyl-peptidase I. Gene characterization, localization, and expression</article-title><source>J Biol Chem</source><year>1997</year><volume>272</volume><fpage>10260</fpage><lpage>10265</lpage><pub-id pub-id-type="pmid">9092576</pub-id><pub-id pub-id-type="doi">10.1074/jbc.272.15.10260</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hart</surname><given-names>TC</given-names></name><name><surname>Hart</surname><given-names>PS</given-names></name><name><surname>Michalec</surname><given-names>MD</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Firatli</surname><given-names>E</given-names></name><name><surname>Van Dyke</surname><given-names>TE</given-names></name><name><surname>Stabholz</surname><given-names>A</given-names></name><name><surname>Zlotogorski</surname><given-names>A</given-names></name><name><surname>Shapira</surname><given-names>L</given-names></name><name><surname>Soskolne</surname><given-names>WA</given-names></name></person-group><article-title>Haim-Munk syndrome and Papillon-Lefevre syndrome are allelic mutations in cathepsin C</article-title><source>J Med Genet</source><year>2000</year><volume>37</volume><fpage>88</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">10662807</pub-id><pub-id pub-id-type="doi">10.1136/jmg.37.2.88</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hart</surname><given-names>TC</given-names></name><name><surname>Hart</surname><given-names>PS</given-names></name><name><surname>Michalec</surname><given-names>MD</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Marazita</surname><given-names>ML</given-names></name><name><surname>Cooper</surname><given-names>M</given-names></name><name><surname>Yassin</surname><given-names>OM</given-names></name><name><surname>Nusier</surname><given-names>M</given-names></name><name><surname>Walker</surname><given-names>S</given-names></name></person-group><article-title>Localization of a gene for prepubertal periodontitis to chromosome 11q14 and identification of a cathepsin C gene mutation</article-title><source>J Med Genet</source><year>2000</year><volume>37</volume><fpage>95</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">10662808</pub-id><pub-id pub-id-type="doi">10.1136/jmg.37.2.95</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haneke</surname><given-names>E</given-names></name></person-group><article-title>The Papillon-Lefevre syndrome: keratosis palmoplantaris with periodontopathy: Report of a case and review of the cases in the literature</article-title><source>Hum Genet</source><year>1979</year><volume>51</volume><fpage>1</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">159254</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Kandt</surname><given-names>RS</given-names></name><name><surname>Wolpert</surname><given-names>C</given-names></name><name><surname>Roses</surname><given-names>AD</given-names></name><name><surname>Pericak-Vance</surname><given-names>MA</given-names></name><name><surname>Gilbert</surname><given-names>JR</given-names></name></person-group><article-title>Mutation analysis of the TSC2 gene in an African-American family</article-title><source>Hum Mol Genet</source><year>1995</year><volume>4</volume><fpage>2295</fpage><lpage>2298</lpage><pub-id pub-id-type="pmid">8634701</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cormand</surname><given-names>B</given-names></name><name><surname>Vilageliu</surname><given-names>L</given-names></name><name><surname>Burguera</surname><given-names>JM</given-names></name><name><surname>Balcells</surname><given-names>S</given-names></name><name><surname>Gonzalez-Duarte</surname><given-names>R</given-names></name><name><surname>Grinberg</surname><given-names>D</given-names></name><name><surname>Chabas</surname><given-names>A</given-names></name></person-group><article-title>Gaucher disease in Spanish patients: analysis of eight mutations</article-title><source>Hum Mutat</source><year>1995</year><volume>5</volume><fpage>303</fpage><lpage>309</lpage><pub-id pub-id-type="pmid">7627184</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hart</surname><given-names>TC</given-names></name><name><surname>Hart</surname><given-names>PS</given-names></name><name><surname>Bowden</surname><given-names>DW</given-names></name><name><surname>Michalec</surname><given-names>MD</given-names></name><name><surname>Callison</surname><given-names>SA</given-names></name><name><surname>Walker</surname><given-names>SJ</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Firatli</surname><given-names>E</given-names></name></person-group><article-title>Mutations of the cathepsin C gene are responsible for Papillon-Lef&#x000e8;vre syndrome</article-title><source>J Med Genet</source><year>1999</year><volume>36</volume><fpage>881</fpage><lpage>887</lpage><pub-id pub-id-type="pmid">10593994</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hart</surname><given-names>PS</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Firatli</surname><given-names>E</given-names></name><name><surname>Uygur</surname><given-names>C</given-names></name><name><surname>Lotfazar</surname><given-names>M</given-names></name><name><surname>Michalec</surname><given-names>MD</given-names></name><name><surname>Marks</surname><given-names>JJ</given-names></name><name><surname>Lu</surname><given-names>X</given-names></name><name><surname>Coates</surname><given-names>BJ</given-names></name><name><surname>Seow</surname><given-names>WK</given-names></name><name><surname>Marshall</surname><given-names>R</given-names></name><name><surname>Williams</surname><given-names>D</given-names></name><name><surname>Reed</surname><given-names>JB</given-names></name><name><surname>Wright</surname><given-names>JT</given-names></name><name><surname>Hart</surname><given-names>TC</given-names></name></person-group><article-title>Identification of cathepsin C mutations in ethnically diverse Papillon-Lefevre syndrome patients</article-title><source>J Med Genet</source><year>2000</year><volume>37</volume><fpage>927</fpage><lpage>932</lpage><pub-id pub-id-type="pmid">11106356</pub-id><pub-id pub-id-type="doi">10.1136/jmg.37.12.927</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakano</surname><given-names>A</given-names></name><name><surname>Nomura</surname><given-names>K</given-names></name><name><surname>Nakano</surname><given-names>H</given-names></name><name><surname>Ono</surname><given-names>Y</given-names></name><name><surname>LaForgia</surname><given-names>S</given-names></name><name><surname>Pulkkinen</surname><given-names>L</given-names></name><name><surname>Hashimoto</surname><given-names>I</given-names></name><name><surname>Uitto</surname><given-names>J</given-names></name></person-group><article-title>Papillon-Lefevre syndrome: mutations and polymorphisms in the cathepsin C gene</article-title><source>J Invest Dermatol</source><year>2001</year><volume>116</volume><fpage>339</fpage><lpage>343</lpage><pub-id pub-id-type="pmid">11180012</pub-id><pub-id pub-id-type="doi">10.1046/j.1523-1747.2001.01244.x</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Lundgren</surname><given-names>T</given-names></name><name><surname>Renvert</surname><given-names>S</given-names></name><name><surname>Tatakis</surname><given-names>DN</given-names></name><name><surname>Firatli</surname><given-names>E</given-names></name><name><surname>Uygur</surname><given-names>C</given-names></name><name><surname>Hart</surname><given-names>PS</given-names></name><name><surname>Gorry</surname><given-names>MC</given-names></name><name><surname>Marks</surname><given-names>JJ</given-names></name><name><surname>Hart</surname><given-names>TC</given-names></name></person-group><article-title>Evidence of a founder effect for four cathepsin gene mutations in Papillon-Lefevre syndrome patients</article-title><source>J Med Genet</source><year>2001</year><volume>38</volume><fpage>96</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">11158173</pub-id><pub-id pub-id-type="doi">10.1136/jmg.38.2.96</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Allende</surname><given-names>LM</given-names></name><name><surname>Garcia-Perez</surname><given-names>MA</given-names></name><name><surname>Moreno</surname><given-names>A</given-names></name><name><surname>Corell</surname><given-names>A</given-names></name><name><surname>Carasol</surname><given-names>M</given-names></name><name><surname>Martinez-Canut</surname><given-names>P</given-names></name><name><surname>Arnaiz-Villena</surname><given-names>A</given-names></name></person-group><article-title>Cathepsin C gene: First compound heterozygous patient with Papillon-Lefevre syndrome and a novel symptomless mutation</article-title><source>Hum Mutat</source><year>2001</year><volume>17</volume><fpage>152</fpage><lpage>153</lpage><pub-id pub-id-type="pmid">11180601</pub-id><pub-id pub-id-type="doi">10.1002/1098-1004(200102)17:2&#x0003c;152::AID-HUMU10&#x0003e;3.3.CO;2-R</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lefevre</surname><given-names>C</given-names></name><name><surname>Blanchet-Bardn</surname><given-names>C</given-names></name><name><surname>Jobard</surname><given-names>F</given-names></name><name><surname>Bouadjar</surname><given-names>B</given-names></name><name><surname>Stalder</surname><given-names>JF</given-names></name><name><surname>Cure</surname><given-names>S</given-names></name><name><surname>Hoffmann</surname><given-names>A</given-names></name><name><surname>Prud'homme</surname><given-names>JF</given-names></name><name><surname>Fischer</surname><given-names>J</given-names></name></person-group><article-title>Novel point mutations, deletions and polymorphisms in the cathepsin C gene in nine families from Europe and North Africa with Papillon-Lefevre syndrome</article-title><source>J Invest Dermatol</source><year>2001</year><volume>117</volume><fpage>1657</fpage><lpage>1661</lpage><pub-id pub-id-type="pmid">11886537</pub-id><pub-id pub-id-type="doi">10.1046/j.0022-202x.2001.01595.x</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Hart</surname><given-names>PS</given-names></name><name><surname>Moretti</surname><given-names>AJ</given-names></name><name><surname>Bouwsma</surname><given-names>OJ</given-names></name><name><surname>Fisher</surname><given-names>EM</given-names></name><name><surname>Dudlicek</surname><given-names>L</given-names></name><name><surname>Pettenati</surname><given-names>MJ</given-names></name><name><surname>Hart</surname><given-names>TC</given-names></name></person-group><article-title>Biochemical and mutational analyses of the cathepsin C gene (CTSC) in three North American families with Papillon-Lefevre syndrome</article-title><source>Hum Mutat</source><year>2002</year><volume>20</volume><fpage>75</fpage><pub-id pub-id-type="pmid">12112662</pub-id><pub-id pub-id-type="doi">10.1002/humu.9040</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hart</surname><given-names>PS</given-names></name><name><surname>Pallos</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Sanchez</surname><given-names>J</given-names></name><name><surname>Kavamura</surname><given-names>I</given-names></name><name><surname>Brunoni</surname><given-names>D</given-names></name><name><surname>Hart</surname><given-names>TC</given-names></name></person-group><article-title>Identification of a novel cathepsin C mutation (p.W185X) in a Brazilian kindred with Papillon-Lefevre syndrome</article-title><source>Mol Genet Metab</source><year>2002</year><volume>76</volume><fpage>145</fpage><lpage>147</lpage><pub-id pub-id-type="pmid">12083812</pub-id><pub-id pub-id-type="doi">10.1016/S1096-7192(02)00031-8</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nusier</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Yassin</surname><given-names>O</given-names></name><name><surname>Hart</surname><given-names>TC</given-names></name><name><surname>Hart</surname><given-names>PS</given-names></name></person-group><article-title>Demonstration of altered splicing with the IVS3-1G&#x0003e; A mutation of the cathepsin C</article-title><source>Mol Genet Metab</source><year>2002</year><volume>75</volume><fpage>280</fpage><lpage>283</lpage><pub-id pub-id-type="pmid">11914041</pub-id><pub-id pub-id-type="doi">10.1006/mgme.2002.3304</pub-id></citation></ref></ref-list></back></article> 